Drug intelligence / Profile preview

budesonide + levosalbutamol hydrochloride

Development stage
Unknown
Modality
Small Molecules
Administration
Inhalation
01

Overview

Budesonide + levosalbutamol hydrochloride is a fixed-dose combination inhalation therapy used primarily for the management of asthma and chronic obstructive pulmonary disease (COPD). It combines two active ingredients with complementary mechanisms: - Budesonide is an inhaled corticosteroid that reduces inflammation in the airways, helping to prevent and control symptoms such as wheezing, coughing, and shortness of breath. - Levosalbutamol hydrochloride (also known as levalbuterol) is a selective beta2-adrenoceptor agonist bronchodilator that relaxes airway smooth muscle, providing rapid relief from bronchospasm. This dual-action approach offers both immediate symptom relief (via bronchodilation) and long-term control of airway inflammation. The medication is typically administered via nebulizer or specialized inhalation devices. Common side effects may include throat irritation, cough, headache, tremor, increased heart rate, and oral candidiasis[1][2][3][5][6][7].

Brand names
Budeven LSBudecide LSBudeven LAxodil LB RespulesR.S. Budepress Levo
Other names
budesonide + levalbuterol hydrochloride
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on budesonide + levosalbutamol hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide + levosalbutamol hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call